Zobrazeno 1 - 10 of 157 pro vyhledávání: '"H. B. Makoski"'
1
Editorial & Opinion
[The responsible performance of radio-oncological services; a comment on the paper by H.-B. Makoski in Strahlenther. Onkol. 171 (1995), 369].
Autor: Heider KM, Schneider G
Publikováno v: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] [Strahlenther Onkol] 1995 Aug; Vol. 171 (8), pp. 484.
Zobrazit plný text záznamu
5
Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial
Autor: Michael Stahl, Ulrich Fink, Michael Molls, W Fett, N Breuer, H Sack, J. R. Siewert, F. W. Eigler, Martin Stuschke, Martin K. Walz, H. B. Makoski, W. Niebel, Siegfried Seeber, Hansjochen Wilke, U. Schmidt
Publikováno v: Journal of Clinical Oncology. 14:829-837
PURPOSE The prognosis of patients with locally advanced esophageal cancer (LAEC) remains poor when treated with local modalities. An intensive preoperative program with chemoradiotherapy was used to evaluate the curative resection rate, pathologic re
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9e5a8d785787e43fed1ce9db836a4e3
https://doi.org/10.1200/jco.1996.14.3.829
Zobrazit plný text záznamu
7
[Radiotherapy of non-malignant diseases: principles and recommendations]
Autor: M H, Seegenschmiedt, H B, Makoski, W, Haase, M, Molls
Publikováno v: Rontgenpraxis; Zeitschrift fur radiologische Technik. 52(10-12)
The plenty options and high quality of radiation therapy for non-malignant disorders is not well known outside the field of radiology. It is necessary to transfer this information to cooperating general practitioners, surgeons, orthopedics and other
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::85b74318bdb572857933de4bc9c9a7a1
https://pubmed.ncbi.nlm.nih.gov/10803052
Zobrazit plný text záznamu
8
[Radiotherapy of follicle center lymphoma. Results of a German multicenter and prospective study. Members of the Study Group 'NHL-early stages']
Autor: H, Sack, A, Hoederath, M, Stuschke, W, Bohndorf, H B, Makoski, R P, Müller, R, Pötter
Publikováno v: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]. 174(4)
Follicle centre lymphoma grade I, II (REAL) or centroblastic-centrocytic lymphoma (Kiel classification) present a well defined clinical entity from a clinical point of view. These lymphomas are not curable by chemotherapy in early or advanced stages.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0eb8740ef59600995ff0d153b13ce47a
https://pubmed.ncbi.nlm.nih.gov/9581177
Zobrazit plný text záznamu
9
Extended field and total central lymphatic radiotherapy in the treatment of early stage lymph node centroblastic-centrocytic lymphomas: results of a prospective multicenter study. Study Group NHL-frühe Stadien
Autor: M, Stuschke, A, Hoederath, H, Sack, R, Pötter, R P, Müller, U, Schulz, J, Karstens, H B, Makoski
Publikováno v: Cancer. 80(12)
A prospective multicenter trial was performed to evaluate survival, patterns of relapse, and toxicity for clinically staged patients with lymph node centroblastic-centrocytic (cb/cc) lymphomas in Stages I-IIIA after large extended field irradiation (
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::da7c40d466579dd23499c99b52dcfbaa
https://pubmed.ncbi.nlm.nih.gov/9404705
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje